Updated Dec 28, 2020 | 10:05 IST
A study suggests that coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones. COVID-19 severity is affected by the proportion of antibodies targeting crucial viral protein | Photo Credit: Pixabay
Washington: Coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones, suggest the findings of a new study.
The findings which were published in Science Immunology identifies new links between the course of the disease and a patient s immune response to it. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals
COVID-19 severity is affected by proportion of antibodies targeting crucial viral protein ANI | Updated: Dec 27, 2020 22:21 IST
Washington [US], December 27 (ANI): Coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones, suggest the findings of a new study.
The findings which were published in Science Immunology identifies new links between the course of the disease and a patient s immune response to it. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintain a protective immune response.
Study reveals COVID-19 severity is affected by proportion of antibodies targeting crucial viral protein ANI | Updated: Dec 25, 2020 09:48 IST
Washington [US], December 25 (ANI): A recent study has revealed that COVID-19 antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases of COVID-19 than in comparison to severe ones.
The findings which were published in Science Immunology identifies new links between the course of the disease and a patient s immune response to it. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintain a protective immune response.
COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.
E-Mail
COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.
The findings identify new links between the course of the disease and a patient s immune response. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintain a protective immune response. This is one of the most comprehensive studies to date of the antibody immune response to SARS-CoV-2 in people across the entire spectrum of disease severity, from asymptomatic to fatal, said Scott Boyd, MD, PhD, associate professor of pathology. We assessed multiple time points and sample types, and also analyzed levels of viral RNA in patient nasopharyngeal